�鶹����

This year at the college's annual National Public Health Week “Conversations and Connections” event, experts explore the health consequences of isolation—and our collective responsibility to address it.

After nearly three years of backorders and pharmacy scrambles, the high-demand weight-loss drugs Ozempic, Wegovy, and Mounjaro are finally back in full supply. The FDA recently declared an end to the nationwide shortage of their active ingredients, semaglutide and tirzepatide. Martin Binks, chair of the Department of Nutrition and Food Studies at George Mason �鶹���� and a researcher and clinician with expertise in obesity, explains what this moment means for patients, providers, and public health.